Showing 1–11 of 11 results
-
Comments & Opinion |
Drugging cancer genomes
- Bissan.Al-lazikani@icr.ac.uk
-
Research |
Therapeutic opportunities within the DNA damage response
- bissan.al-lazikani@icr.ac.uk
-
Research |
A comprehensive map of molecular drug targets
- Bissan.Al-Lazikani@icr.ac.uk
-
Research |
Objective assessment of cancer genes for drug discovery
- bissan.al.lazikani@icr.ac.uk
-
Reviews |
How many drug targets are there?
- Bissan Al-Lazikani graduated in Molecular Biology from...
-
Reviews |
Minimum information about a bioactive entity (MIABE)
- Bissan Al-Lazikani leads the computational biology and...
- Sandra Orchard
- , Bissan Al-Lazikani
- , Steve Bryant
- , Dominic Clark
- , Elizabeth Calder
- , Ian Dix
- , Ola Engkvist
- , Mark Forster
- , Anna Gaulton
- , Michael Gilson
- , Robert Glen
- , Martin Grigorov
- , Kim Hammond-Kosack
- , Lee Harland
- , Andrew Hopkins
- , Christopher Larminie
- , Nick Lynch
- , Romeena K. Mann
- , Peter Murray-Rust
- , Elena Lo Piparo
- , Christopher Southan
- , Christoph Steinbeck
- , David Wishart
- , Henning Hermjakob
- , John Overington
- & Janet Thornton
-
Correspondence |
Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group
- Bissan Al-Lazikani is at the Cancer Research...
- Sandra Orchard
- , Bissan Al-Lazikani
- , Steve Bryant
- , Dominic Clark
- , Elizabeth Calder
- , Ian Dix
- , Ola Engkvist
- , Mark Forster
- , Anna Gaulton
- , Michael Gilson
- , Robert Glen
- , Martin Grigorov
- , Kim Hammond-Kosack
- , Lee Harland
- , Andrew Hopkins
- , Christopher Larminie
- , Nick Lynch
- , Romeena K. Mann
- , Peter Murray-Rust
- , Elena Lo Piparo
- , Christopher Southan
- , Christoph Steinbeck
- , David Wishart
- , Henning Hermjakob
- , John Overington
- & Janet Thornton
-
Reviews |
Drug discovery in advanced prostate cancer: translating biology into therapy
- Bissan Al-Lazikani is a computational biologist with...
-
Reviews |
Genomic-scale prioritization of drug targets: the TDR Targets database
- Bissan Al-Lazikani, Ian M. Carruthers,...
- Fernán Agüero
- , Bissan Al-Lazikani
- , Martin Aslett
- , Matthew Berriman
- , Frederick S. Buckner
- , Robert K. Campbell
- , Santiago Carmona
- , Ian M. Carruthers
- , A. W. Edith Chan
- , Feng Chen
- , Gregory J. Crowther
- , Maria A. Doyle
- , Christiane Hertz-Fowler
- , Andrew L. Hopkins
- , Gregg McAllister
- , Solomon Nwaka
- , John P. Overington
- , Arnab Pain
- , Gaia V. Paolini
- , Ursula Pieper
- , Stuart A. Ralph
- , Aaron Riechers
- , David S. Roos
- , Andrej Sali
- , Dhanasekaran Shanmugam
- , Takashi Suzuki
- , Wesley C. Van Voorhis
- & Christophe L. M. J. Verlinde
-
Reviews |
-
Research | | Open
The kinase polypharmacology landscape of clinical PARP inhibitors
- Bissan.Al-Lazikani@icr.ac.uk
